A steadier way to approach weight loss.
For some patients, weight loss is not about trying harder. It is about changing the pattern — less hunger, less noise around food, and a plan that feels easier to stay with over time. Our semaglutide program is designed for people who want a more considered medical option, with proper evaluation, thoughtful dosing, and follow-up that does not disappear after the first visit.
What is Semaglutide?
GLP-1 Therapy
Semaglutide is a prescription GLP-1 medication used as part of a physician-guided weight-loss program. It is designed to support adults who need more than diet and exercise alone, offering a more advanced clinical approach to appetite control and long-term weight management.
Appetite Support
Semaglutide works with the body’s natural appetite signals to help reduce hunger, improve fullness, and support better portion control. By making it easier to stay consistent with healthy habits, it can help patients build steadier progress without relying on extreme dieting or constant willpower alone.
Why Semaglutide?
More Than Willpower
Semaglutide can help support weight loss in a way that feels more manageable, especially for patients who feel like hunger and cravings have made progress harder to sustain.
Helps Reduce Hunger
Semaglutide may help reduce appetite and support better control over day-to-day hunger, making it easier for some patients to stay consistent with their plan.
Fits Into Real Life
With a simple weekly treatment approach, semaglutide can be easier to maintain than plans that feel overly restrictive or hard to follow.
More Than Willpower
Semaglutide may help reduce appetite and support better control over day-to-day hunger, making it easier for some patients to stay consistent with their plan.
Semaglutide by the Numbers
SIMPLE. STRUCTURED. CATERED.
What Treatment Can Look Like
A Personalized Starting Point
Treatment typically begins with a review of your goals, health history, and weight-loss needs to help determine whether semaglutide is a good fit.
A Simple Weekly Routine
For many patients, treatment becomes part of a consistent routine that feels manageable and easy to follow over time.
Ongoing Support Over Time
Follow-up, progress check-ins, and adjustments can help keep treatment aligned with your goals as your needs evolve.
Is this program right for you?
You're likely a good candidate if:
This program is not appropriate if you have:
Frequently Asked Questions
Safety Information You Should Know
⚠ Risk of Thyroid C-Cell Tumors
In animal studies, semaglutide caused thyroid tumors, including medullary thyroid carcinoma (MTC). It is not known whether semaglutide causes these tumors in humans. Do not use semaglutide if you or any family member has ever had MTC or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
Semaglutide is the active ingredient in FDA-approved medications for chronic weight management and type 2 diabetes, and has been studied extensively. Our program uses compounded semaglutide, prepared by licensed U.S. compounding pharmacies. Like any prescription medication, it carries potential risks — here's everything our medical team screens for before prescribing.
Contraindications
Do not take semaglutide if you:
Common Side Effects
Most side effects improve as your body adjusts to the medication, especially during dose increases. Our team starts every patient on a low dose and titrates up slowly to minimize discomfort.
Every patient in our program receives:
- A thorough medical history review before any prescription is written
- Lab work when clinically indicated
- Regular provider check-ins throughout your treatment
- Direct access to our medical team for questions or concerns
- Medication sourced only from licensed, FDA-registered compounding pharmacies
We'd rather turn away a patient who isn't a good fit than put anyone at unnecessary risk. If semaglutide isn't right for you, we'll tell you — and help you explore other options.
Research & Clinical Srouces
The STEP trials were funded by Novo Nordisk, the manufacturer of semaglutide. SURMOUNT-5 was funded by Eli Lilly. These funding sources are standard for pharmaceutical drug development and do not invalidate the findings — all studies were published in peer-reviewed journals after independent review — but it is worth noting for transparency. Individual patient results may differ from clinical trial averages, which is why our program includes thorough medical evaluation and ongoing monitoring for every patient.